✦ LIBER ✦

Antitumour necrosis factor-α antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis

✍ Scribed by M. Fischer ; E. Fiedler ; W.C. Marsch ; J. Wohlrab

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 408 KB
Volume: 146
Category: Article
ISSN: 0007-0963
DOI: 10.1046/j.1365-2133.2002.46833.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pneumocystis jirovecipneumonia in a pati

Pneumocystis jirovecipneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor α neutralizing antibody

✍ Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Kanako Ito; Yukinori Koga; Izum 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 350 KB

Successful treatment of active ankylosin

Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab

✍ Jan Brandt; Hildrun Haibel; Daniel Cornely; Werner Golder; José Gonzalez; Jaquel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Development of interstitial pneumonia in

Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

✍ Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Mineharu Sugimoto 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 326 KB

Tumor necrosis factor α haplotypes versu

Tumor necrosis factor α haplotypes versus tumor necrosis factor α −308 G/A polymorphism in the prediction of infliximab treatment efficacy in rheumatoid arthritis

✍ Bénédicte Mugnier; Jean Roudier 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

Development of myeloperoxidase-antineutr

Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α

✍ Daigoro Hirohama; Junichi Hoshino; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Ha 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 219 KB

Assessment of antibodies to double-stran

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

✍ P. J. Charles; R. J. T. Smeenk; J. De Jong; M. Feldmann; R. N. Maini 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Objective. To compare the incidence of antidouble-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor ␣ (anti-TNF␣) antibody or placebo infusions, with or without methotrexate, in open-label, ra